For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Research and development | 10,211 | |||
| General and administrative | 9,650 | |||
| Severance and related charges | 0 | |||
| Total operating expenses | 19,861 | |||
| Interest income | 421 | |||
| Loss from operations | -19,440 | |||
| Net loss | -19,440 | |||
| Basic EPS | -4.44 | |||
| Diluted EPS | -4.44 | |||
| Basic Average Shares | 4,374,328 | |||
| Diluted Average Shares | 4,374,328 | |||
IN8BIO, INC. (INAB)
IN8BIO, INC. (INAB)